← Leaderboards
Cory Mabry
Texas A&M University Health Science Ctr
$76,013
Attributed
$76,013
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $38.4K · FY2024–25$50K$37.5K$25K$12.5K$0
'24
'25
Funding mix
By agency
NIH$76,013 · 1
By mechanism
F31$76,013 · 1
Top collaborators
No co-investigators on record.
Most similar at Texas A&M University Health Science Ctr
Same institution · by research overlap
- Paul D Gershon$6,073,054
- Jiang Chang$12,014,555
- Sylvia Torres-Odio$71,362
Others in their field
Other Rising Stars on “Anti-Bacterial Agents”
- Paul Sebahar · Curza Inc$2,858,436
- Zheng Yan · University Of Missouri-Columbia$2,588,415
- Ryan Bock · Sintx Technologies, Inc.$2,548,555
- Vidmantas Petraitis · Hackensack University Medical Center$2,359,697
- Brian Kane · Spero Therapeutics, Inc.$2,105,800
- Tsuyoshi Uehara · Venatorx Pharmaceuticals, Inc.$2,000,000
Research focus
Anti-Bacterial AgentsAllelesApoptosisApoptoticBiochemistryAntiviral ImmunityBlack BoxCell DeathCell NucleusCell PhysiologyCell ProliferationCellsDefectDesignDisease ModelExperimental StudyFamily MemberFemaleFutureGene ExpressionGenerationsHomeostasisHost DefenseHuman Pathogen
Grant awards (2)
TRIM 14 is a master regulator of STAT3 activity during the macrophage innate immune responses to Mycobacterium tuberculosis$38,361
F31 · FY2025 · AI · contact PI
TRIM 14 is a master regulator of STAT3 activity during the macrophage innate immune responses to Mycobacterium tuberculosis$37,652
F31 · FY2024 · AI · contact PI